PARTNER II Trial: S3iCAP

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1822 participants.

Also called NCT02687035

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,822 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02687035
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02687035. Allocation not applicable; no masking; primary purpose treatment. Start 2015-01 (actual); primary completion 2017-10 (actual). Results posted on 2021-04-08.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
PARTNER II Trial: S3iCAP
Acronym
PII S3i CAP
Condition
Aortic Stenosis
Intervention (Device)
SAPIEN S3 valve
Lead sponsor
Edwards Lifesciences (class: industry)

Record details

Record id
cardio:ct-nct02687035
Content hash
d85c53fdee4f58d0b2b647d1a2e7c2a175ceba83e04a2d67bdb4cc6b9a8226ef